Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gene therapy

Showing results (51-60 of 4,884) with videos related to

Pageof 489
Sort By:
Gene Therapy|September 22, 2021
Spotlight on gene therapy in GermanyClaudio Mussolino, Patrick Harrison
Gene Therapy|November 21, 2023
Modeling Glutaric Aciduria Type I in human neuroblastoma cells recapitulates neuronal damage that can be rescued by gene replacementA Mateu-Bosch, E Segur-Bailach, J García-Villoria, et al.
Gene Therapy|November 16, 2023
Overexpression of KCNN4 channels in principal neurons produces an anti-seizure effect without reducing their coding abilityEvgeny S Nikitin, Tatiana Y Postnikova, Elena Y Proskurina, et al.
Gene Therapy|September 11, 2023
A pilot study to determine the optimal dose of scAAVIL-1ra in a large animal model of post-traumatic osteoarthritisP Thampi, K A Seabaugh, L M Pezzanite, et al.
Gene Therapy|August 11, 2023
Biodistribution of lentiviral transduced adipose-derived stem cells for "ex-vivo" regional gene therapy for bone repairJennifer A Bell, Kevin Collon, Cory Mayfield, et al.
Gene Therapy|August 4, 2023
CRISPR/sgRNA-directed synergistic activation mediator (SAM) as a therapeutic tool for Parkinson´s diseaseLuis Fernando Narváez-Pérez, Francisco Paz-Bermúdez, José Arturo Avalos-Fuentes, et al.
Gene Therapy|August 16, 2023
Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primatesTricia H Burdo, Chen Chen, Rafal Kaminski, et al.
Gene Therapy|August 23, 2023
Selection of appropriate non-clinical animal models to ensure translatability of novel AAV-gene therapies to the clinicMark Singh, Andrew Brooks, Parto Toofan, et al.
Gene Therapy|January 15, 2003
Oligonucleotide-directed single-base DNA alterations in mouse embryonic stem cellsE A Pierce, Q Liu, O Igoucheva, et al.
Gene Therapy|January 15, 2003
Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcomeM F Cordeiro, A Mead, R R Ali, et al.
Pageof 489

Showing results (51-60 of 4,884) with videos related to

Sort By:
Pageof 489
Gene Therapy|September 22, 2021
Spotlight on gene therapy in GermanyClaudio Mussolino, Patrick Harrison
Gene Therapy|November 21, 2023
Modeling Glutaric Aciduria Type I in human neuroblastoma cells recapitulates neuronal damage that can be rescued by gene replacementA Mateu-Bosch, E Segur-Bailach, J García-Villoria, et al.
Gene Therapy|November 16, 2023
Overexpression of KCNN4 channels in principal neurons produces an anti-seizure effect without reducing their coding abilityEvgeny S Nikitin, Tatiana Y Postnikova, Elena Y Proskurina, et al.
Gene Therapy|September 11, 2023
A pilot study to determine the optimal dose of scAAVIL-1ra in a large animal model of post-traumatic osteoarthritisP Thampi, K A Seabaugh, L M Pezzanite, et al.
Gene Therapy|August 11, 2023
Biodistribution of lentiviral transduced adipose-derived stem cells for "ex-vivo" regional gene therapy for bone repairJennifer A Bell, Kevin Collon, Cory Mayfield, et al.
Gene Therapy|August 4, 2023
CRISPR/sgRNA-directed synergistic activation mediator (SAM) as a therapeutic tool for Parkinson´s diseaseLuis Fernando Narváez-Pérez, Francisco Paz-Bermúdez, José Arturo Avalos-Fuentes, et al.
Gene Therapy|August 16, 2023
Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primatesTricia H Burdo, Chen Chen, Rafal Kaminski, et al.
Gene Therapy|August 23, 2023
Selection of appropriate non-clinical animal models to ensure translatability of novel AAV-gene therapies to the clinicMark Singh, Andrew Brooks, Parto Toofan, et al.
Gene Therapy|January 15, 2003
Oligonucleotide-directed single-base DNA alterations in mouse embryonic stem cellsE A Pierce, Q Liu, O Igoucheva, et al.
Gene Therapy|January 15, 2003
Novel antisense oligonucleotides targeting TGF-beta inhibit in vivo scarring and improve surgical outcomeM F Cordeiro, A Mead, R R Ali, et al.
Pageof 489